Cargando…
Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
BACKGROUND AND AIMS: Platelet-derived growth factor receptor alpha (PDGFRα) is suggested as a prognosis marker for hepatocellular carcinoma (HCC). Since PDGFRα is also known as a marker for activated hepatic stellate cells (HSCs), this study aimed to investigate whether PDGFRα expression in HCC was...
Autores principales: | Yu, Jung-Hwan, Kim, Joon Mee, Kim, Ja Kyung, Choi, Suk Jin, Lee, Kwan Sik, Lee, Jin-Woo, Chang, Hye Young, Lee, Jung Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503630/ https://www.ncbi.nlm.nih.gov/pubmed/28465473 http://dx.doi.org/10.18632/oncotarget.17134 |
Ejemplares similares
-
Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice
por: Lim, Beom Jin, et al.
Publicado: (2018) -
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022) -
Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
por: Lee, Jung Il, et al.
Publicado: (2019) -
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C
por: Yu, Jung Hwan, et al.
Publicado: (2017) -
Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view
por: Lee, Jung Yeon, et al.
Publicado: (2016)